Sign in
4

Changes in Ownership

Sarepta Therapeutics, Inc. Filed Acc 0001209191-19-016044

Options or other derivatives

  • EVP, R&D & CMO acquired 55,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

O'Neill Gilmore Neil · EVP, R&D & CMO

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2019-03-04 Grant or award : show line 1 in the form Stock option (right to buy) +55,000 $145.48 2029-03-04 55,000 55,000 D
Loading xslF345X03/doc4.xml…